1. Down‐regulated expression of miR‐134 contributes to paclitaxel resistance in human ovarian cancer cells. Issue 20 (9th September 2015) Authors: Shuang, Ting; Wang, Min; Shi, Cong; Zhou, Yingying; Wang, Dandan Journal: FEBS letters Issue: Volume 589:Issue 20(2015) Part B Page Start: 3154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extremely high serum CA19-9 level along with elevated D-dimer in assisting detection of ruptured ovarian endometriosis. (31st December 2022) Authors: Shuang, Ting; Wang, Yiran; Zhao, Lanbo; Zhang, Kailu; Yin, Panyue; Guo, Lin; Jing, Wei; Feng, Xue; Li, Qiling Journal: Annals of medicine Issue: Volume 54:Number 1(2022) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization. (1st April 2022) Authors: Zhao, Zongxia; Shuang, Ting; Gao, Yan; Lu, Fan; Zhang, Jinbao; He, Wei; Qu, Lijuan; Chen, Biliang; Hao, Qiang Journal: Cancer letters Issue: Volume 530(2022) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗